Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2026)

Vivos Therapeutics (VVOS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.78 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 29.2% year-over-year to 0.78 in Q1 2026; TTM through Mar 2026 was 0.78, a 29.2% decrease from a year earlier, with the FY2025 full-year figure at 0.86, down 25.34% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.78, up from 0.69 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for VVOS reached as high as 1.31 in Q4 2023 and fell as low as 0.54 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.92 across 5 years, with a median of 0.98 in 2024.
• Across the five-year window, Asset Utilization Ratio jumped 120.75% in 2022 and plunged 30.02% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 1.0 in 2022, then soared by 31.44% to 1.31 in 2023, then declined by 25.16% to 0.98 in 2024, then plunged by 30.02% to 0.69 in 2025, then gained by 13.53% to 0.78 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.78 in Q1 2026, 0.69 in Q4 2025, and 0.67 in Q3 2025.